Posttraumatic Total Knee Arthroplasty Continues to Have Worse Outcome Than Total Knee Arthroplasty for Osteoarthritis.
Matthew T Houdek, Chad D Watts, Steven F Shannon...
https://pubmed.ncbi.nlm.nih.gov/26264176Actively Recruiting
Led by Central Finland Hospital District · Updated on 2024-08-22
98
Participants Needed
8
Research Sites
156 weeks
Total Duration
C
Central Finland Hospital District
Lead Sponsor
T
Tampere University Hospital
Collaborating Sponsor
Researchers are comparing two treatments for intra-articular proximal tibia fractures in patients aged 65 and older. The study evaluates knee function and pain one year after treatment using either locking plate osteosynthesis (ORIF) or primary total knee replacement (TKR). These fractures are common in the elderly and often come with complications like osteoporosis and risk of losing independent walking ability. The study addresses the need to compare traditional ORIF treatment with TKR as a primary option, as no randomized controlled trials have done so before. The study involves two treatment groups. One group receives osteosynthesis with locking plates through incisions based on the fracture's shape, with possible use of bone transplantation and additional fixation. Post-surgery, patients follow a weight-bearing schedule starting with limited weight for six weeks. The other group undergoes total knee replacement within two weeks of fracture, using a medial parapatellar approach with prosthesis tailored for stability and bone condition. Patients in this group are allowed full weight bearing as tolerated after surgery. Participants undergo assessments at multiple points up to 10 years, including knee function, pain, physical performance, quality of life, satisfaction, and any reoperations. The main outcome measure is knee function at 12 months. Researchers will use these evaluations to compare the effects of both treatments. The study lasts for many years with follow-ups to monitor long-term results and safety.
CONDITIONS
Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 weeks for surgery and immediate recovery
Participants receive either osteosynthesis with locking plate or total knee arthroplasty as primary treatment for their proximal tibial fracture.
1 surgical procedure visit
Duration - Up to 12 months after treatment
Participants are followed to monitor recovery, knee function, pain, physical performance, and quality of life over time.
Visits at 6 weeks, 3 months, 6 months, and 12 months
Total: 8 locations
1
Central Finland Hospital
Jyväskylä, Finland, 40620
Actively Recruiting
2
Kuopio University Hospital
Kuopio, Finland
Not Yet Recruiting
3
Päijät-Häme Central Hospital
Lahti, Finland
Not Yet Recruiting
4
Oulu University Hospital
Oulu, Finland
Not Yet Recruiting
5
Seinäjoki Central Hospital
Seinäjoki, Finland
Not Yet Recruiting
6
Coxa Joint Replacement Hospital
Tampere, Finland
Not Yet Recruiting
7
Tampere University Hospital
Tampere, Finland
Not Yet Recruiting
8
Turku University Hospital
Turku, Finland
Not Yet Recruiting
J
Juha Paloneva, MD, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Matthew T Houdek, Chad D Watts, Steven F Shannon...
https://pubmed.ncbi.nlm.nih.gov/26264176David Wasserstein, Patrick Henry, J Michael Paterson...
https://pubmed.ncbi.nlm.nih.gov/24430414Axel Somersalo, Juha Paloneva, Hannu Kautiainen...
https://pubmed.ncbi.nlm.nih.gov/24694275Ajay Malviya, Mike R Reed, Paul F Partington
https://pubmed.ncbi.nlm.nih.gov/21763651Sunil Gurpur Kini, S S Sathappan
https://pubmed.ncbi.nlm.nih.gov/23771128Takaki Shimizu, Takeshi Sawaguchi, Daigo Sakagoshi...
https://pubmed.ncbi.nlm.nih.gov/26671570Thomas Haufe, Stefan Förch, Peter Müller...
https://pubmed.ncbi.nlm.nih.gov/26885510